Heyholder
‹ Activism Filings

ADBIOTECH Co.,Ltd. Q3 revenue KRW 7.2 billion, operating loss KRW 1.2 billion

ADBIOTECH Co.,Ltd.· Periodic Report

AI summary · Not investment advice

In Q3, the company sold KRW 7.2 billion worth and lost KRW 1.2 billion from its main business; sales rose 97.3% from a year earlier and 146.3% from the prior quarter.

Operating profit · 3 months

KRW -1.2 billion

Key facts

Revenue (3 months)
KRW 7.2 billion
Net income (3 months)
KRW -1.9 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 3.6 billion
Revenue (year to date)
KRW 13.1 billion
Operating profit (prior-year 3 months)
KRW -1.8 billion
Operating profit (year to date)
KRW -4.2 billion
Net income (prior-year 3 months)
KRW -4.8 billion
Net income (year to date)
KRW -7.6 billion

Commentary

AI commentary · Not investment advice

What happened

Advbiotech reported its consolidated results for the 3rd quarter of 2026. Sales for the 3 months were KRW 7.15 billion. That is 97.3% higher than the same 3 months a year earlier, which had KRW 3.63 billion. It is also 146.3% higher than the previous quarter. Cumulative sales for the year are KRW 13.13 billion.

In the company's terms

Operating profit (profit from the core business) for the 3 months was a loss of KRW 1.16 billion. In the same period a year earlier, the operating loss was KRW 1.76 billion. The cumulative operating loss for the year is KRW 4.16 billion.

What changes for shareholders

Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 1.93 billion. A year earlier, the net loss for the same period was KRW 4.81 billion. The cumulative net loss for the year is KRW 7.62 billion.

Comments

No comments yet

Comments from shareholders will appear here.